WFA
OM icon

Wipfli Financial Advisors’s Outset Medical OM Stock Holding History

Wipfli Financial Advisors’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$2K Buy
+7
New +$1.87K ﹤0.01% 2304

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Wipfli Financial Advisors's OM Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in Outset Medical (OM) in Q3 2022: 7 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #2304 among its holdings.

138 funds tracked by Wall St. Rank hold OM as of Q3 2022.

  • Wipfli Financial Advisors held 7 shares of Outset Medical worth $2K as of Q3 2022.
  • Outset Medical was a new Wipfli Financial Advisors position in Q3 2022.
  • Outset Medical made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #2304 holding.
  • 138 funds tracked by Wall St. Rank held Outset Medical as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.